Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.87B | $1.91B | -2.00% |
Gross Profit | $1.11B | $1.13B | -1.44% |
Net Income | $221.81M | $213.93M | +3.69% |
EPS (Basic) | $18.70 | $18.28 | +2.30% |
EPS (Diluted) | $18.60 | $18.15 | +2.48% |
R&D Expense | $92.19M | $92.72M | -0.58% |
SG&A Expense | $470.19M | $463.23M | +1.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.25B | $3.37B | -3.60% |
Current Assets | $1.18B | $1.25B | -5.47% |
Total Liabilities | $3.4B | $3.46B | -1.68% |
Current Liabilities | $1.28B | $1.01B | +27.10% |
Stockholders' Equity | $-152.76M | $-89.7M | -70.29% |
Cash & Equivalents | $70.81M | $83.57M | -15.27% |
Long-Term Debt | $1.75B | $2.05B | -14.61% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $447.49M | $420.07M | +6.53% |
Investing Cash Flow | $-30.77M | $-65.3M | +52.88% |
Financing Cash Flow | $-413.39M | $-365.06M | -13.24% |
Share Buybacks | $425M | $500M | -15.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 59.5% | 59.1% | +0.33% |
Net Margin | 11.8% | — | — |
ROE | -145.2% | — | — |
ROA | 6.8% | — | — |
Current Ratio | $0.92 | — | — |
Debt to Equity | $-22.269 | — | — |
Other companies in Life Sciences Tools & Services